Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
109,277,591
-
Share change
-
-2,940,249
-
Total reported value
-
$852,398,662
-
Put/Call ratio
-
35%
-
Price per share
-
$7.80
-
Number of holders
-
138
-
Value change
-
-$22,775,753
-
Number of buys
-
66
-
Number of sells
-
61
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q2 2016
As of 30 Jun 2016,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
109,277,591 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, FMR LLC, JANUS CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, GOLDMAN SACHS GROUP INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
138
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.